Loading: 100%
Integra Lifesciences Holdings Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 3,700 (as per Q1 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker IARTno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173642485460
datesClosing price (adj.)
13.10.201749.17
11.10.201749.59
04.10.201751.77
27.09.201750.25
20.09.201748.89
13.09.201752.40
06.09.201751.48
30.08.201750.00
23.08.201750.14
16.08.201750.03
09.08.201749.81
02.08.201747.80
26.07.201749.74
19.07.201755.76
12.07.201754.73
05.07.201754.07
27.06.201753.74
20.06.201753.52
13.06.201752.45
06.06.201751.25
30.05.201749.88
23.05.201747.97
16.05.201746.91
09.05.201746.83
02.05.201746.44
25.04.201743.74
18.04.201741.09
11.04.201741.30
04.04.201741.45
28.03.201742.60
21.03.201742.68
14.03.201743.03
07.03.201742.15
28.02.201742.74
21.02.201743.97
14.02.201743.28
07.02.201742.39
31.01.201741.73
24.01.201741.35
17.01.201742.47
10.01.201744.90
03.01.201742.59
27.12.201643.22
19.12.201642.06
12.12.201640.52
05.12.201638.39
28.11.201641.42
21.11.201641.15
14.11.201639.54
07.11.201639.21
31.10.201639.76
24.10.201641.15
17.10.201640.38
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
49.17n/a
Market Capitalisation
in million USD
3,718n/a
Enterprise Value
in million USD
4,438n/a
Common Shares Outstanding
as per Apr 24, 2017
75,620,857n/a
Preferred Shares Outstanding
as per Apr 24, 2017
n/a
Average Basic Shares Outstanding
TTM
56,027,500n/a
Average Diluted Shares Outstanding
TTM
79,676,000n/a
Index Membership
n/a
Business Summary
Integra Lifesciences Holdings Corp is engaged in development, manufacturing, and marketing of product lines from its technology for applications ranging from burn and deep tissue wounds to repair of dura mater in the brain to repair of nerve and tendon.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 1,014n/a
Gross Profit 663n/a
Operating Income 103n/a
EBITDA 0n/a
Net Profit 68n/a
Balance Sheet
Cash and Cash Equivalents 135n/a
Receivables 158n/a
Total Current Assets 569n/a
PP&E 229n/a
Total Assets 2,049n/a
Accounts Payable 46n/a
Current Debt 6n/a
Total Current Liabilities 188n/a
Long-Term Debt 849n/a
Total Liabilities 1,197n/a
Total Equity 852n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 65.4%n/a
Operating Margin 10.2%n/a
Net Profit Margin 6.7%n/a
Return on Equity 7.9%n/a
Return on Assets 3.3%n/a
Per Share Figures
Basic EPS 1.21n/a
Diluted EPS 0.85n/a
Sales per Share 18.10n/a
Book Value per Share 15.22n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 40.79n/a
Price to Sales Ratio 2.72n/a
Price to Book Value 3.23n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 4.38n/a
Book to Market Value 0.23n/a
Other Ratios
Current Ratio 302.5%n/a
Liabilities to Equity Ratio 140.4%n/a
Debt to Assets Ratio 41.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
655
682
732
780
831
697
797
883
992
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-253
-245
-268
-299
-314
-280
-303
-327
-349
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
402
438
464
481
516
417
494
556
643
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-354
-340
-365
-426
-443
-382
-426
-477
-528
Selling, General & Administrative
-281
-281
-305
-358
-373
-332
-376
-416
-456
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-60
-44
-48
-51
-51
-43
-44
-51
-58
Depreciation & Amortization
-13
-14
-12
-16
-19
-7
-7
-10
-14
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
47
98
99
55
74
35
68
80
115
Non-Operating Income (Loss)
-29
-25
-17
-26
-22
-17
-22
-19
-25
Interest Expense, net
-28
-23
-18
-27
-21
-15
-22
-24
-26
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
-2
2
1
-1
-2
0
5
1
Pretax Income (Loss), Adjusted
19
73
82
28
52
19
46
61
90
Abnormal Gains (Losses)
0
0
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
19
73
82
28
52
19
46
61
90
Income Tax (Expense) Benefit, net
9
-22
-16
-1
-11
3
-9
-54
-16
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
28
51
66
28
41
22
36
7
75
Net Extraordinary Gains (Losses)
0
0
0
0
0
-43
-2
-10
0
Discontinued Operations
0
0
0
0
0
-43
-2
-10
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
28
51
66
28
41
-21
34
-4
75
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
28
51
66
28
41
-21
34
-4
75
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
28
51
66
28
41
-21
34
-4
75
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
72
129
101
97
121
72
48
102
Cash & Cash Equivalents
n/a
72
129
101
97
121
72
48
102
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
103
106
118
115
118
110
132
148
Accounts Receivable, Net
n/a
103
106
118
115
118
110
132
148
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
140
147
171
172
207
189
211
217
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
50
63
62
69
75
158
47
28
Prepaid Expenses
n/a
20
28
26
30
27
28
43
28
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
30
35
36
39
49
31
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
100
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
4
0
Total Current Assets
n/a
365
445
452
453
521
529
438
495
Property, Plant & Equipment, Net
n/a
84
99
131
178
200
194
205
222
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
491
475
560
533
471
864
1,131
1,090
Intangible Assets
n/a
211
195
237
212
197
413
604
561
Goodwill
n/a
262
262
293
294
250
363
512
511
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
16
8
17
16
15
4
7
7
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
74
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
2
10
13
10
8
10
7
12
Total Noncurrent Assets
n/a
575
574
692
711
671
1,058
1,336
1,313
Total Assets
n/a
940
1,019
1,144
1,164
1,192
1,587
1,774
1,808
Liabilities and owners' equity
Payables & Accruals
n/a
76 75893000
89 88975000
97 97325000
103 103424000
115 115185000
103 103319000
119 119086000
117 116789000
Accounts Payable
n/a
25 24598000
28 27783000
28 27656000
37 36742000
51 50752000
29 28867000
35 34772000
29 29057000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
51 51295000
61 61192000
70 69669000
67 66682000
64 64433000
74 74452000
84 84314000
88 87732000
Short Term Debt
n/a
77 76760000
108 108438000
0 0
0 0
0 0
4 3750000
14 14375000
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
4 4077000
4 4444000
5 4543000
4 3505000
4 4197000
19 18956000
6 5666000
7 6812000
Deferred Revenue
n/a
4 4077000
4 4444000
5 4543000
4 3505000
4 4197000
5 5176000
6 5666000
7 6812000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
14 13780000
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
157 156730000
202 201857000
102 101868000
107 106929000
119 119382000
126 126025000
139 139127000
124 123601000
Long Term Debt
n/a
309 308754000
295 294842000
532 532264000
520 519547000
392 392057000
626 626246000
700 700115000
665 665000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
30 29733000
22 22471000
17 17339000
19 19348000
15 14610000
131 130826000
184 183539000
180 179686000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
9 9319000
11 10645000
6 5726000
5 5393000
2 2083000
100 100417000
155 154891000
149 148941000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
3 2631000
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
20 20414000
12 11826000
12 11613000
14 13955000
13 12527000
28 27778000
29 28648000
31 30745000
Total Noncurrent Liabilities
n/a
338 338487000
317 317313000
550 549603000
539 538895000
407 406667000
757 757072000
884 883654000
845 844686000
Total Liabilities
n/a
495 495217000
519 519170000
651 651471000
646 645824000
526 526049000
883 883097000
1,023 1022781000
968 968287000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
521 521199000
553 552586000
608 608033000
588 587670000
751 751328000
780 779971000
1,021 1020587000
799 799429000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-252 -252380000
-284 -283658000
-367 -367121000
-367 -367121000
-367 -367121000
-367 -367121000
-367 -367121000
-123 -123051000
Retained Earnings
n/a
167 167161000
233 232830000
261 260819000
302 302023000
281 280956000
315 314960000
146 145879000
220 220443000
Other Equity
n/a
9 8905000
-2 -1795000
-9 -9093000
-5 -4797000
1 927000
-23 -23488000
-48 -47902000
-57 -57154000
Equity Before Minority Interest
n/a
445 444885000
500 499963000
493 492638000
518 517775000
666 666090000
704 704322000
751 751443000
840 839667000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
445 444885000
500 499963000
493 492638000
518 517775000
666 666090000
704 704322000
751 751443000
840 839667000
Total Liabilities & Equity
n/a
940 940102000
1,019 1019133000
1,144 1144109000
1,164 1163599000
1,192 1192139000
1,587 1587419000
1,774 1774224000
1,808 1807954000
Remarks restated on n/a restated on Feb 24, 2011 n/a restated on Feb 27, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 27, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 26, 2016 n/a restated on Feb 23, 2017 n/a restated on Apr 26, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
28
51
66
28
41
22
36
7
75
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
31
40
39
50
53
31
46
59
73
Non-Cash Items
38
29
26
41
20
19
18
63
23
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-5
24
-26
-15
-54
-19
-38
-12
-54
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
91
144
106
104
59
53
63
117
116
Change in Fixed Assets & Intangibles
-13
-25
-37
-38
-69
-42
-38
-33
-47
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-87
-61
-5
-152
-7
-3
-321
-329
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-19
-2
0
0
-3
0
0
-4
4
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-119
-88
-42
-190
-79
-45
-360
-366
-43
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
260
-100
88
147
142
-135
230
79
169
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
43
0
152
0
220
0
Increase in Capital Stock
0
0
0
43
0
152
0
220
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
260
-100
88
190
142
17
230
299
169
Net Cash Before Disc. Operations and FX
232
-45
151
104
122
25
-67
50
242
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
232
-45
151
104
122
25
-67
50
242
Effect of Foreign Exchange Rates
0
5
-5
-2
5
2
-8
-5
-5
Net Changes in Cash
233
-40
147
102
127
27
-74
45
237
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo